"Emollients to Prevent Pediatric Eczema: A Randomized Clinical Trial"
JAMA Network
July 2025
Don Nease, MD, and other members of the State Network of Colorado Ambulatory Practices and Partners (SNOCAP) team, were contributors to the recent publication entitled "Emollients to Prevent Pediatric Eczema: A Randomized Clinical Trial."
Dr. Nease had the following to say about this publication:
"This is the culmination of many years of work with our sister networks in the MetaLARC consortium that was originally funded by AHRQ. That includes a planning grant that we were a part of, and then this large randomized controlled trial.
Pediatric atopic dermatitis, or eczema, has a high prevalence in Colorado, and for those families with a child who experiences this condition, the burden on the families is equivalent to having a child diagnosed with type 1 diabetes. This is the first large, randomized trial to demonstrate that daily use of over-the-counter emollients can help reduce the risk of this condition.
From the SNOCAP team, Mary Fisher, MPH; Cat Halliwell; and Meredith Warman, MPH, worked on the project, and our network leads helped with practice recruitment. I might add that in addition to the clinical importance of the study, this served as really solid evidence for the NIH that Practice Based Research Networks (PBRNs) can implement large randomized controlled trials, and helped Oregon and Wisconsin’s PBRNs get funded as a part of the NIH’s Care for Health initiative pilots with PBRNs."
Congrats on the culmination of your hard work, team!
.png)
